Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q1 2018 (← Previous) (Next →)
Filing Date: May 15, 2018
Total Value: $1.341B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | NEKTAR THERAPEUTICS | 2,563,200 | $272M | 20.3% | $69.99 | — | COM | 640268108 |
| — | NEKTAR THERAPEUTICS | 1,530,900 | $163M | 12.1% | $69.99 | — | Call | 640268108 |
| ANAB | ANAPTYSBIO INC | 1,104,022 | $115M | 8.6% | $34.01 | +231.4% | COM | 032724106 |
| APLS | APELLIS PHARMACEUTICALS INC | 4,088,229 | $90.39M | 6.7% | $15.11 | +30.1% | COM | 03753U106 |
| — | MIRATI THERAPEUTICS INC | 1,918,350 | $58.89M | 4.4% | $19.29 | — | COM | 60468T105 |
| IFRX | INFLARX NV | 1,399,030 | $40.35M | 3.0% | $17.97 | +46.7% | COM | N44821101 |
| — | BLUEPRINT MEDICINES CORP | 432,063 | $39.62M | 3.0% | $67.43 | — | COM | 09627Y109 |
| — | SAGE THERAPEUTICS INC | 239,619 | $38.59M | 2.9% | $161.07 | — | COM | 78667J108 |
| — | MYOKARDIA INC | 767,363 | $37.45M | 2.8% | $17.38 | — | COM | 62857M105 |
| — | DICERNA PHARMACEUTICALS INC | 3,600,954 | $34.42M | 2.6% | $9.03 | — | COM | 253031108 |
| TBPH | THERAVANCE BIOPHARMA INC | 1,300,000 | $31.52M | 2.3% | $24.80 | +10.7% | COM | G8807B106 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,519,891 | $28.5M | 2.1% | $16.31 | 0.0% | COM | 77313F106 |
| — | G1 THERAPEUTICS INC | 719,985 | $26.68M | 2.0% | $20.91 | — | COM | 3621LQ109 |
| ASND | ASCENDIS PHARMA A S | 371,739 | $24.31M | 1.8% | $44.95 | — | SPONSORED ADR | 04351P101 |
| — | AVEXIS INC | 192,094 | $23.74M | 1.8% | $110.67 | — | COM | 05366U100 |
| ARGX | ARGENX SE | 278,536 | $22.41M | 1.7% | $63.14 | — | SPONSORED ADR | 04016X101 |
| — | QUOTIENT LTD | 4,290,852 | $20.21M | 1.5% | $9.14 | — | SHS | G73268107 |
| — | CLEARSIDE BIOMEDICAL INC | 1,880,880 | $20.18M | 1.5% | $7.30 | — | COM | 185063104 |
| — | TESARO INC | 350,000 | $20M | 1.5% | $57.14 | — | COM | 881569107 |
| VNDA | VANDA PHARMACEUTICALS INC | 957,821 | $16.14M | 1.2% | $16.74 | 0.0% | COM | 921659108 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 191,112 | $15.85M | 1.2% | $15.30 | +452.1% | COM | 64125C109 |
| OMER | OMEROS CORP | 1,314,118 | $14.68M | 1.1% | $16.18 | -13.2% | COM | 682143102 |
| QTRX | QUANTERIX CORP | 847,789 | $14.45M | 1.1% | $19.52 | +2.7% | COM | 74766Q101 |
| ANAB | ANAPTYSBIO INC | 129,400 | $13.47M | 1.0% | $34.01 | +231.4% | Call | 032724106 |
| — | MENLO THERAPEUTICS INC | 336,714 | $12.65M | 0.9% | $37.58 | — | COM | 586858102 |
| — | ARRAY BIOPHARMA INC | 668,743 | $10.91M | 0.8% | $6.75 | — | COM | 04269X105 |
| OMER | OMEROS CORP | 969,000 | $10.82M | 0.8% | $16.18 | -13.2% | Call | 682143102 |
| — | AUDENTES THERAPEUTICS INC | 322,945 | $9.704M | 0.7% | $18.38 | — | COM | 05070R104 |
| — | REATA PHARMACEUTICALS INC | 450,000 | $9.23M | 0.7% | $25.22 | — | CL A | 75615P103 |
| ACRS | ACLARIS THERAPEUTICS INC | 525,538 | $9.207M | 0.7% | $19.94 | +6.3% | COM | 00461U105 |
| — | ABEONA THERAPEUTICS INC | 549,404 | $7.884M | 0.6% | $8.20 | — | COM | 00289Y107 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 284,735 | $7.335M | 0.5% | $26.98 | — | COM | G11196105 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 286,668 | $7.324M | 0.5% | $17.28 | +37.9% | COM | 19459J104 |
| SGMO | SANGAMO THERAPEUTICS INC | 382,192 | $7.262M | 0.5% | $6.37 | +235.4% | COM | 800677106 |
| ZLAB | ZAI LAB LTD | 333,166 | $7.113M | 0.5% | $27.00 | — | ADR | 98887Q104 |
| — | KADMON HOLDINGS INC | 1,648,432 | $7.006M | 0.5% | $4.25 | — | COM | 48283N106 |
| — | GEMPHIRE THERAPEUTICS INC | 1,041,635 | $6.781M | 0.5% | $9.88 | — | COM | 36870A108 |
| — | CONTRAFECT CORP | 3,392,234 | $5.394M | 0.4% | $2.80 | — | COM | 212326102 |
| HRTX | HERON THERAPEUTICS INC | 191,108 | $5.275M | 0.4% | $15.72 | +44.3% | COM | 427746102 |
| — | SOLID BIOSCIENCES INC | 685,958 | $5.138M | 0.4% | $7.49 | — | COM | 83422E105 |
| — | ARENA PHARMACEUTICALS INC | 125,000 | $4.938M | 0.4% | $39.50 | — | COM NEW | 040047607 |
| — | INTEC PHARMA LTD JERUSALEM | 773,816 | $4.894M | 0.4% | $5.59 | — | SHS | M53644106 |
| — | TRILLIUM THERAPEUTICS INC | 573,208 | $4.127M | 0.3% | $4.40 | — | COM NEW | 89620X506 |
| — | MINERVA NEUROSCIENCES INC | 607,903 | $3.799M | 0.3% | $7.26 | — | COM | 603380106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 382,139 | $3.283M | 0.2% | $13.67 | +37.8% | COM | 74366E102 |
| EOLS | EVOLUS INC | 342,400 | $3.092M | 0.2% | $11.44 | 0.0% | COM | 30052C107 |
| — | ACCELERON PHARMA INC | 71,667 | $2.802M | 0.2% | $32.04 | — | COM | 00434H108 |
| — | JOUNCE THERAPEUTICS INC | 82,988 | $1.855M | 0.1% | $21.80 | — | COM | 481116101 |
| — | MARINUS PHARMACEUTICALS INC | 478,111 | $1.826M | 0.1% | $8.16 | — | COM | 56854Q101 |
| — | ONCOBIOLOGICS INC | 416,666 | $18,000 | 0.0% | $0.45 | — | *W EXP 05/18/201 | 68235M121 |
| — | ONCOBIOLOGICS INC | 416,666 | $15,000 | 0.0% | $0.46 | — | *W EXP 02/18/201 | 68235M113 |
| — | CELLECTAR BIOSCIENCES INC | 52,999 | $6,000 | 0.0% | $0.55 | — | *W EXP 08/20/201 | 15117F120 |